ASP Isotopes (ASPI) Current Deferred Revenue (2023 - 2026)

ASP Isotopes' Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $7.4 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 567.66% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (up 567.66% YoY), while the FY2025 annual figure was $882000.0, down 78.72% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $7.4 million, up from $882000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $7.4 million in Q1 2026, with the low at $882000.0 in Q4 2023.
• The 4-year median for Current Deferred Revenue is $882000.0 (2023), against an average of $2.0 million.
• The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue tumbled 78.72% in 2025, then soared 567.66% in 2026.
• ASP Isotopes' Current Deferred Revenue stood at $882000.0 in 2023, then jumped by 369.84% to $4.1 million in 2024, then sank by 78.72% to $882000.0 in 2025, then jumped by 733.9% to $7.4 million in 2026.
• Business Quant data shows ASPI's Current Deferred Revenue at $7.4 million in Q1 2026, $882000.0 in Q4 2025, and $882000.0 in Q3 2025.